+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A double-blind, crossover trial of mefenamic acid, sulindac and flurbiprofen in rheumatoid arthritis

A double-blind, crossover trial of mefenamic acid, sulindac and flurbiprofen in rheumatoid arthritis

Current Medical Research and Opinion 5(10): 754-758

A double-blind crossover trial was carried out in 24 patients to compare the effects of mefenamic acid, flurbiprofen, sulindac and placebo. Each drug was given for 2 weeks, the treatment sequence being randomized. Daily doses were 1500 mg mefenamic acid, 150 mg flurbiprofen or 150 mg sulindac. All of the active drugs were significantly superior to placebo in terms of pain score, patients' assessment, articular index of joint tenderness, and duration and severity of morning stiffness. There was improvement in grip strength compared with placebo, but the differences were not statistically significant with sulindac. There was slight reduction in joint circumference but this was only statistically significant in the right hand with flurbiprofen and sulindac. No significant differences were found in technetium uptake in knee joints. The three drugs appeared to be equally effective and tolerated, and no significant differences were noted.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 039061009

Download citation: RISBibTeXText

PMID: 373989

DOI: 10.1185/03007997909109009

Related references

Flurbiprofen and indomethacin in the treatment of rheumatoid arthritis: a double-blind crossover study. Current Medical Research and Opinion 5(1): 77-84, 1977

Double-blind crossover trial comparing ibuprofen with flufenamic acid in rheumatoid arthritis. Rheumatology and Physical Medicine 10: Suppl 10:76-82, 1970

Flurbiprofen and indomethacin in rheumatoid arthritis and osteo arthrosis of the knee a comparative multicenter double blind crossover study. Zeitschrift fuer Rheumatologie 40(2): 87-92, 1981

Oxaprozin and sulindac in rheumatoid arthritis: a double-blind comparative trial. Current Medical Research and Opinion 8(5): 302-309, 1983

Plasmapheresis therapy in rheumatoid arthritis. A controlled, double-blind, crossover trial. New England Journal of Medicine 308(19): 1124-1129, 1983

Indoprofen vs. indomethacin and placebo a double blind 3 way crossover trial in rheumatoid arthritis. European Journal of Rheumatology & Inflammation 4(1): 74-78, 1981

Double-blind crossover trial of naproxen and placebo in patients with rheumatoid arthritis. Scandinavian Journal of Rheumatology. Suppl. 2: 132-136, 1973

Randomized double blind crossover trial of low dose methotrexate for rheumatoid arthritis. Arthritis & Rheumatism 28(4 Suppl.): S69, 1985

Ketoprofen and indomethacin in the treatment of rheumatoid arthritis a double blind crossover trial. European Journal of Clinical Pharmacology 8(3-4): 205-208, 1975

Mefenamic acid in the therapy of rheumatoid arthritis. Clinical experiments and biohumoral control with the double-blind method. (Preliminary observations). Reumatismo 19(3): 180-182, 1967

A double blind crossover trial of methyl prednisolone pulse therapy in rheumatoid arthritis. Arthritis & Rheumatism: 711, 1980

Endocrine control of inflammation: rheumatoid arthritis double-blind, crossover clinical trial. International Journal of Clinical Pharmacology Research 12(1): 11-18, 1992

Controlled trial of cyclo phosphamide in rheumatoid arthritis an 18 month double blind crossover study. Arthritis & Rheumatism 15(1): 129-130, 1972

Trans cutaneous nerve stimulation on patients with rheumatoid arthritis a double blind crossover trial. Scandinavian Journal of Rheumatology 6(2): 75, 1977

A double blind multicenter study of sulindac once daily versus sulindac twice daily in rheumatoid arthritis. Current Therapeutic Research 41(5): 679-691, 1987